Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2001 Mar;92(3):309–315. doi: 10.1111/j.1349-7006.2001.tb01096.x

Successful Induction of Tumor‐specific Cytotoxic T Lymphocytes from Patients with Non‐small Cell Lung Cancer Using CD80‐transfected Autologous Tumor Cells

Mitsuhiro Takenoyama 1,✉, Ichiro Yoshino 1, Ryozo Eifuku 1, Tomoko So 1, Satoru Imahayashi 1, Masakazu Sugaya 1, Manabu Yasuda 1, Masaaki Inoue 1, Yuji Ichiyoshi 1, Toshihiro Osaki 1, Akira Nagashima 2, Kikuo Nomoto 3, Kosei Yasumoto 1
PMCID: PMC5926714  PMID: 11267941

Abstract

Cytotoxic T lymphocytes (CTL) against human lung cancer cells are difficult to induce by a conventional method using tumor cell stimulation probably due to an insufficiency of tumor antigens (TA) or costimulatory molecules such as CD80. We, therefore, investigated the potential of CD80‐transfected tumor cells as stimulators of the in vitro induction of autologous tumor‐specific CTL from regional lymph node lymphocytes in patients with lung cancer. Five non‐small cell lung cancer cell lines (two adenocarcinomas, 1 squamous cell carcinoma, 1 large cell carcinoma and 1 adenosquamous cell carcinoma) were established from surgical specimens and were successfully transduced with a plasmid constructed with expression vector pBj and human CD80 cDNA, using a lipofection method. CD80‐transfected tumor cells (CD80‐AT) significantly augmented the proliferation of autologous lymphocytes from all cases as compared with non‐transfected tumor cells (AT). AT‐stimulated lymphocytes from 4 out of 5 cases did not show any cytotoxicity against AT; however, lymphocytes stimulated with CD80‐AT exhibited substantial cytotoxicity against parental AT in all 5 cases tested. AT‐stimulated lymphocytes derived from only one out of 5 cases showed major histocompatibility complex (MHC)‐class I‐restricted cytokine production in response to AT, while the MHC‐class I‐restricted responses were found in CD80‐AT‐stimulated lymphocytes from 4 out of 5 cases. These results indicate that CD80 on tumor cells could be a beneficial costimulatory molecule to elicit CTL against lung cancer, and also show that TA recognized by CTL was frequently expressed on lung cancer cells.

Keywords: Lung cancer, CTL, CD80, Regional lymph node, Autologous tumor cells

Full Text

The Full Text of this article is available as a PDF (88.1 KB).

References

  • 1.van den Eynde , B. J . and van der Bruggen , P. Tcell defined tumor antigensCurr. Opin. Immunol , 9 , 684 – 693 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 2.Rosenberg , S. A . A new era for cancer immunotherapy based on the genes that encode cancer antigens . Immunity , 10 , 281 – 287 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 3.Shichijo , S. , Nakao , M. , Imai , Y. , Takasu , H. , Kawamoto , M. , Niiya , R , Yang , D. , Toh , Y. , Yamana , H . and Itoh , K . A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes . J. Exp. Med. , 187 , 277 – 288 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Gueguen , M. , Patard , J. J. , Gaugler , B. , Brasseur , F. , Renauld , J. C. , van Cangh , P. J. , Boon , T . and van den Eynde , B. J . An antigen recognized by autologous CTLs on a human bladder carcinoma . J. Immunol , 160 , 6188 – 6194 ( 1998. ). [PubMed] [Google Scholar]
  • 5.Schwartz , R. H . A cell culture model for T lymphocyte clonal anergy . Science , 248 , 1349 – 1356 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 6.Liu , Y . and Janeway , C. A . , Jr. Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self‐tolerance . J. Exp. Med. , 172 , 1735 – 1739 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Chen , L. , Ashe , S. , Brady , W. A. , Hellstrom , I. , Hellstrom , K. E. , Ledbetter , J. A. , McGowan , P . and Linsley , P. S . Costimulation of antitumor immunity by the B7 counter‐receptor for the T lymphocyte molecules CD28 and CTLA‐4 . Cell , 71 , 1093 – 1102 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 8.Townsend , S. E . and Allison , J. P . Tumor rejection after direct costimulation of CD8+ T cells by B7‐transfected melanoma cells . Science , 259 , 368 – 370 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 9.Yang , S. , Darrow , T. L . and Seigler , H. F . Generation of primary tumor‐specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I‐matched allo‐geneic peripheral blood lymphocytes by B7 gene‐modified melanoma cells . Cancer Res. , 57 , 1561 – 1568 ( 1997. ). [PubMed] [Google Scholar]
  • 10.Kaufmann , A. M. , Gissmann , L. , Street , D. , Schreckenberger , C. , Hunter , M . and Qiao , L . Expression of CD80 enhances immunogenicity of cervical carcinoma cells in vitro . Cell. Immunol , 169 , 246 – 251 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 11.Takenoyama , M. , Yoshino , L , Fujie , H. , Hanagiri , T. , Yoshimatsu , T. , Imabayashi , S. , Eifuku , R. , Nomoto , K . and Yasumoto , K . Autologous tumor‐specific cytotoxic T lymphocytes in a patient with lung adenocarcinoma: implications of the shared antigens expressed in HLA‐A24 lung cancer cell . Jpn. J. Cancer Res. , 89 , 60 – 66 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Yasumoto , K. , Ohta , M . and Nomoto , K . Cytotoxic activity of lymphocytes to bronchogenic carcinoma cells in patients with lung cancer . Gann , 67 , 505 – 512 ( 1976. ). [PubMed] [Google Scholar]
  • 13.Yoshino , I. , Yano , T. , Murata , M. , Ishida , T. , Sugimachi , K. , Kimura , G . and Nomoto , K . Tumor‐reactive T‐cells accumulate in lung cancer tissues but fail to respond due to tumor cell‐derived factor . Cancer Res. , 52 , 775 – 781 ( 1992. ). [PubMed] [Google Scholar]
  • 14.Nagashima , A. , Yasumoto , K. , Nakahashi , H. , Takeo , S. , Yano , T. , Motohiro , A. , Furukawa , T. , Inokuchi , K . and Nomoto , K . Antitumor activity of pleural cavity macro‐phages and its regulation by pleural cavity lymphocytes in patients with lung cancer . Cancer Res. , 47 , 5497 – 5500 ( 1987. ). [PubMed] [Google Scholar]
  • 15.Azuma , M. , Cayabyab , M. , Buck , D. , Phillips , J. H . and Lanier , L. L . Involvement of CD28 in MHC‐unrestricted cytotoxicity mediated by a human natural killer leukemia cell line . J. Immunol. , 149 , 1115 – 1123 ( 1992. ). [PubMed] [Google Scholar]
  • 16.Yaita , H. , Yasumoto , K. , Nagashima , A. , Sugimachi , K . and Nomoto , K . Antitumor activity of regional lymph node lymphocytes in patients with lung cancer . J. Surg. Oncol. , 38 , 165 – 172 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 17.Grili , R. , Oxman , A. D . and Julian , J. A . Chemotherapy for advanced non‐small‐cell lung cancer: how much benefit is enough ? J. Clin. Oncol. , 11 , 1855 – 1872 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 18.Damstrup , L . and Poulson , H. S . Review of the curative role of radiotherapy in the treatment of non‐small cell lung cancer . Lung Cancer , 11 , 153 – 178 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 19.Yoshino , L , Goedegebuure , P. , Peoples , G. E. , Parikh , A. S. , Dimaio , J. M. , Lyerly , H. K. , Gazdar , A. F . and Eberlein , T. J . HER2/neu‐derived peptides are shared antigens among human non‐small cell lung cancer and ovarian cancer . Cancer Res. , 54 , 3387 – 3390 ( 1994. ). [PubMed] [Google Scholar]
  • 20.Slingluff , C. L. , Cox , A. L. , Stover , J. M. , Jr. , Moore , M. M. , Hunt , D. F . and Engelhard , V. H . Cytotoxic T‐lympho‐cyte response to autologous human squamous cell cancer of the lung: epitope reconstruction with peptides extracted from HLA‐Aw68 . Cancer Res. , 54 , 2731 – 2737 ( 1994. ). [PubMed] [Google Scholar]
  • 21.O'Mahony , A. M. , O'Sullivan , G. C. , O'Connell , J. , Cotter , T. G . and Collins , J. K . An immune suppressive factor derived from esophageal squamous carcinoma induces apo‐ptosis in normal and transformed cells of lymphoid lineage . J. Immunol. , 151 , 4847 – 4856 ( 1993. ). [PubMed] [Google Scholar]
  • 22.Yoshino , L , Yano , T. , Miyamoto , M. , Yamada , K. , Kajii , Y. , Onodera , K. , Ishida , T. , Sugimachi , K. , Kimura , G . and Nomoto , K . Characterization of lung squamous cell carcinoma‐derived T‐cell suppressive factor . Cancer , 72 , 2347 – 2357 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 23.Gimmi , C. D. , Morrison , B. W. , Mainprice , B. A. , Gribben , J. G. , Boussiotis , V. A. , Freeman , G. J. , Park , S. Y. , Watanabe , M. , Gong , J. , Hayes , D. F. , Kufe , D. W . and Nadler , L. M . Breast cancer‐associated antigen, DF3/ MUC1, induces apoptosis of activated human T cells . Nat. Med. , 2 , 1367 – 1370 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 24.Strand , S. , Hofmann , W. J. , Hug , H. , Muller , M. , Otto , G. , Strand , D. , Mariani , S. M. , Stremmel , W. , Krammer , P. H . and Galle , P. R . Lymphocyte apoptosis induced by CD95 (APO‐1/Fas) ligand‐expressing tumor cells: a mechanism of immune evasion ? Nat. Med. , 2 , 1361 – 1366 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 25.Chen , L. , Linsley , P. S. and Hellstrom , K. E . Costimulation of T cells for tumor immunity . Immunol. Today , 14 , 483 – 486 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 26.Mogi , S. , Ebata , T. , Setoguchi , Y. , Fujime , M. , Heike , Y. , Kohsaka , T. , Yagita , H. , Okumura , K . and Azuma , M . Efficient generation of autologous peripheral blood‐derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80‐adenovirus together with interleukin 12 and interleukin 2 . Clin. Cancer Res. , 4 , 713 – 720 ( 1998. ). [PubMed] [Google Scholar]
  • 27.van der Bruggen , P. , Traversari , C. , Chomez , P. , Lurquin , C. , de Plean , E. , van den Eynde , B. , Knuth , A . and Boon , T . A gene encoding an antigen recognized by cytolytic T lymphocytes on a melanoma . Science , 254 , 1643 – 1647 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 28.Rosenberg , S. A. , Yang , J. C. , Schwartzentruber , D. J. , Hwu , P. , Marincola , F. M. , Topalian , S. L. , Restifo , N. P. , Dudley , M. E. , Schwarz , S. L. , Spiess , P. J. , Wunderlich , J. R. , Parkhurst , M. R. , Kawakami , Y. , Seipp , C. A. , Einhorn , J. H . and White , D. E . Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma . Nat. Med. , 4 , 321 – 327 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Nestle , F. O. , Alijagic , S. , Gilliet , M. , Sun , Y. , Grabbe , S. , Dummer , R. , Burg , G . and Schadendorf , D . Vaccination of melanoma patients with peptide‐ or tumor lysate‐pulsed dendritic cells . Nat. Med. , 4 , 328 – 332 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 30.Marchand , M. , van Baren , N. , Weynants , P. , Brichard , V. , Dreno , B. , Tessier , M. H. , Rankin , E. , Parmiani , G. , Arienti , F. , Humblet , Y. , Bourlond , A. , Vanwijck , R. , Lienard , D. , Beauduin , M. , Dietrich , P. Y. , Russo , V. , Kerger , J. , Masucci , G. , Jager , E. , de Greve , J. , Atzpodien , J. , Brasseur , F. , Coulie , P. G. , van der Bruggen , P . and Boon T . Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1 . Int. J. Cancer , 80 , 219 – 230 ( 1999. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES